Table 4.
Patterns of communicable and non-communicable disease multimorbidity in LMICs.
Author (year) | Statistical method | Multimorbidity patterns |
---|---|---|
*Chang et al. (2019) 22 | Descriptive analysis | Anemia + HIV (2.6%) |
Hypertension + HIV (1.9%) | ||
Hypertension +anemia + HIV (2.6%) | ||
Dyslipidemia + anemia + HIV (2.0%) | ||
Ahmadi et al. (2016) 26 | Descriptive analysis | Tuberculosis + gastro-esophageal reflux disease (7.3%) |
Cardiovascular disease + tuberculosis (4.6%) | ||
Chronic obstructive pulmonary disease + tuberculosis (1.9%) | ||
Pati et al. (2017) 24 | Descriptive analysis | Men group (dyad) |
Acid peptic disease + arthritis (7.9%) | ||
Acid peptic disease + hypertension (7.0%) | ||
Acid peptic disease + chronic backache (6.6%) | ||
Women group (dyad) | ||
Acid peptic disease + hypertension (10.5%) | ||
Acid peptic disease + arthritis (10.2%) | ||
Acid peptic disease + chronic backache (8.1%) | ||
Men group (triad) | ||
Acid peptic disease + arthritis + chronic backache (3.6%) | ||
Arthritis + acid peptic disease + hypertension (2.4%) | ||
Acid peptic disease + hypertension + chronic backache (2.3%) | ||
Women group (triad) | ||
Arthritis + acid peptic disease + chronic backache (4.1%) | ||
Arthritis + acid peptic disease + hypertension (3.1%) | ||
Arthritis + hypertension + chronic backache (2.3%) | ||
Oni et al. (2015) 6 | Descriptive analyses | Double morbidities |
Hypertension + HIV (21.4%) | ||
HIV + tuberculosis (6.2%) | ||
HIV + type 2 diabetes mellitus (1.6%) | ||
Triple morbidities | ||
Hypertension + type 2 diabetes mellitus + HIV (63.0%) | ||
Hypertension + tuberculosis + HIV (26.6%) | ||
Hypertension + tuberculosis + type 2 diabetes mellitus (6.9%) |